Evidence map›Paper›PMID 36503244›Full record

ArticleMolecular pharmaceutics2023

Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation.

Eloy Pena-Rodríguez, Laura García-Vega, Maria Lajarin Reinares, Marçal Pastor-Anglada, Sandra Pérez-Torras, Francisco Fernandez-Campos

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Eloy Pena-RodríguezLaboratory Reig Jofre, R&D Department, 08970Sant Joan Despi, Barcelona, Spain.ORCID 0000-0001-8743-7229
Laura García-VegaMolecular Pharmacology and Experimental Therapeutics, Department of Biochemistry and Molecular. Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona (IBUB), 08028Barcelona, Spain.ORCID 0000-0002-6226-6985
Maria Lajarin ReinaresLaboratory Reig Jofre, R&D Department, 08970Sant Joan Despi, Barcelona, Spain.
Marçal Pastor-AngladaMolecular Pharmacology and Experimental Therapeutics, Department of Biochemistry and Molecular. Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona (IBUB), 08028Barcelona, Spain.
Sandra Pérez-TorrasMolecular Pharmacology and Experimental Therapeutics, Department of Biochemistry and Molecular. Biomedicine, Institute of Biomedicine (IBUB), University of Barcelona (IBUB), 08028Barcelona, Spain.
Francisco Fernandez-CamposLaboratory Reig Jofre, R&D Department, 08970Sant Joan Despi, Barcelona, Spain.
Instituto de Salud Carlos III · ESReig Jofre (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Latanoprost (LAT) has been shown to have a hypertrichotic effect, which makes it a promising candidate for alopecia treatments. For the first time, LAT has been encapsulated in nanotransfersomes in order to increase its efficacy.

Indexed as

KeratinocytesScalpAnimalsCell ProliferationHair FollicleHumansLatanoprostSwineTissue DistributionLatanoprostbiodistributionconfocal laser microscopyHaCaT, sonicationhair folliclehuman skinlatanoprostnanotransfersomespig skin

Identifiers

PMID36503244
PMCPMC10155202
OpenAlexW4311204157

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.